Comparison Between Two Local Anaesthetics Given In Interpleural Block For Control Of Pain In Patients Undergoing Breast Surgery
Phase 4
- Conditions
- Health Condition 1: null- 18 YEARS TO 65 YEARS OLD PATEINTS UNDERGOING BREAST SURGERY FOR MALIGNANT OR BENIGN CONDITIONS UNDER ASA GRADE I and II
- Registration Number
- CTRI/2018/04/012981
- Lead Sponsor
- VARDHMAN MAHAVIR MEDICAL COLLEGE AND SAFDARJUNG HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)ASA grade I and II
2)Age between 18 to 65 years
3)Patients scheduled for elective surgery under general anaesthesia for any lesion in the breast benign or malignant
Exclusion Criteria
1)Patients with history of allergy to local anaesthetics
2)Patients with severe renal,hepatic,respiratory,cardiac,neurologic disorders
3)patients with history of opiod,cocaine abuse
4)Patients on anticoagulants
5)Patients with psychiatric illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)To find out whether levobupivacaine is better than ropivacaine in interpleural block in providing longer duration of analgesia in patients undergoing breast surgery <br/ ><br>2)Total number of rescue analgesics required in post -operative 24 hours by patients of each group <br/ ><br>3)Total no of times fentanyl was givenn intraoperatively after induction in each group <br/ ><br>Timepoint: 1)To find out whether levobupivacaine is better than ropivacaine in interpleural block in providing longer duration of analgesia in patients undergoing breast surgery <br/ ><br>2)Total number of rescue analgesics required in post -operative 24 hours by patients of each group <br/ ><br>3)Total no of times fentanyl was givenn intraoperatively after induction in each group <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1)Any complications of the block or pertaining to drugTimepoint: post-operative 24 hrs